The vascular lesion treatment laser market size has grown rapidly in recent years. It will grow from $1.83 billion in 2025 to $2.03 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to growth in vascular disorders, cosmetic dermatology demand, laser technology advancement, outpatient treatment preference, clinical efficacy validation.
The vascular lesion treatment laser market size is expected to see rapid growth in the next few years. It will grow to $3.04 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to aesthetic procedure growth, pediatric dermatology expansion, laser system innovation, clinic-based treatment demand, aging population. Major trends in the forecast period include non-invasive aesthetic treatments, demand for scar-free procedures, pediatric vascular treatment growth, cosmetic dermatology expansion, outpatient laser procedures.
The rising demand for minimally invasive procedures is expected to drive growth in the vascular lesion treatment laser market. These procedures are performed through small incisions or natural body openings, resulting in less tissue damage, quicker recovery times, and fewer complications compared to traditional surgeries. The appeal of minimally invasive methods lies in their ability to reduce pain, shorten hospital stays, and enable patients to return to their normal activities faster than with conventional surgeries. Vascular lesion treatment lasers enhance the benefits of these procedures by precisely targeting abnormal blood vessels, minimizing tissue damage, and promoting quicker recovery with less scarring. According to the American Society of Plastic Surgeons in June 2024, minimally invasive procedures saw a 7% increase in 2023, outpacing the growth of traditional surgeries by 2%. This surge in demand is a key factor driving the expansion of the vascular lesion treatment laser market.
Companies in the vascular lesion treatment laser market are increasingly focusing on developing advanced solutions, such as dual-wavelength laser platforms, to improve treatment precision and patient comfort. These platforms combine two laser wavelengths in one system, allowing for more effective targeting of various vascular lesions while minimizing damage to surrounding tissue. For example, in April 2025, Candela Medical Inc., a US-based medical device company, introduced the Vbeam Pro laser platform, which integrates a 595 nm pulsed dye laser and a 1064 nm Nd:YAG wavelength. This dual-wavelength system is FDA-cleared for use in pediatric patients and offers greater precision and versatility for treating a range of vascular and dermatologic conditions, such as rosacea, port-wine stains, acne, and spider veins. The system also improves lesion clearance by 20%, reduces treatment times by 50%, and cuts patient discomfort by 20%, marking a significant advancement in pulsed dye laser technology.
In June 2023, Hahn and Company, a private equity firm based in South Korea, acquired Lutronic, a company specializing in advanced laser systems for treating vascular lesions. This acquisition strengthens Hahn and Company’s presence in the medical aesthetics market, leveraging Lutronic's innovative technologies and global reach to expand their offerings in this field.
Major companies operating in the vascular lesion treatment laser market are Lumenis Ltd., Candela Corporation, DEKA M.E.L.A. S.r.l., Alma Lasers Ltd., Quanta System S.p.A., Fotona d.o.o., Asclepion Laser Technologies GmbH, Aerolase Inc., Lynton Lasers Ltd., Sciton Inc., Cynosure Inc., Cutera Inc., Venus Concept Inc., Biolitec AG, El.En. S.p.A., SharpLight Technologies Ltd., Beijing Nubway S And T Co. Ltd., Beijing Sincoheren S And T Development Co. Ltd., Wuhan Gigaa Optronics Technology Co. Ltd., Nanjing Bestview Laser Co. Ltd.
North America was the largest region in the vascular lesion treatment laser market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular lesion treatment laser market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular lesion treatment laser market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased the cost of imported laser components, optical systems, cooling units, and electronic controls used in vascular lesion treatment lasers, raising equipment prices across the market. These impacts are most pronounced in advanced laser technologies such as pulsed dye, Nd:YAG, and diode lasers, particularly in Asia-Pacific and Europe where many high precision components are sourced internationally. Higher device costs have affected purchasing decisions in hospitals and dermatology clinics. However, tariffs have also encouraged local manufacturing and assembly of laser systems, supporting regional supply chains and improving long term cost stability.
The vascular lesion treatment laser market research report is one of a series of new reports that provides vascular lesion treatment laser market statistics, including vascular lesion treatment laser industry global market size, regional shares, competitors with a vascular lesion treatment laser market share, detailed vascular lesion treatment laser market segments, market trends and opportunities, and any further data you may need to thrive in the vascular lesion treatment laser industry. This vascular lesion treatment laser market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A vascular lesion treatment laser is a specialized medical laser system designed to target and treat abnormal or visible blood vessels, such as spider veins, hemangiomas, or port-wine stains, by delivering focused light energy. The laser selectively heats and collapses the blood vessels without damaging surrounding skin, resulting in clearer and healthier looking tissue.
The primary types of vascular lesion treatment lasers include telangiectasia, hemangiomas, varicose veins, and port wine stains. Telangiectasia refers to small, widened blood vessels visible on the skin’s surface, which can be treated with lasers to reduce redness and visible veins. Treatment technologies include pulsed dye lasers, neodymium-doped yttrium aluminum garnet lasers, intense pulsed light, diode lasers, and erbium lasers. These lasers are applied in areas such as aesthetic procedures, medical treatments, cosmetic enhancements, skin resurfacing, and tattoo removal. End users include hospitals, dermatology clinics, cosmetic surgery centers, ambulatory surgical centers, and home care settings.
The vascular lesion treatment laser market consists of revenues earned by entities by providing services such as spider vein removal, port-wine stain treatment, hemangioma treatment, rosacea management, telangiectasia treatment, and leg vein therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The vascular lesion treatment laser market also includes sales of alexandrite lasers, krypton lasers, argon lasers, copper vapor lasers, and ruby lasers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The vascular lesion treatment laser market size is expected to see rapid growth in the next few years. It will grow to $3.04 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to aesthetic procedure growth, pediatric dermatology expansion, laser system innovation, clinic-based treatment demand, aging population. Major trends in the forecast period include non-invasive aesthetic treatments, demand for scar-free procedures, pediatric vascular treatment growth, cosmetic dermatology expansion, outpatient laser procedures.
The rising demand for minimally invasive procedures is expected to drive growth in the vascular lesion treatment laser market. These procedures are performed through small incisions or natural body openings, resulting in less tissue damage, quicker recovery times, and fewer complications compared to traditional surgeries. The appeal of minimally invasive methods lies in their ability to reduce pain, shorten hospital stays, and enable patients to return to their normal activities faster than with conventional surgeries. Vascular lesion treatment lasers enhance the benefits of these procedures by precisely targeting abnormal blood vessels, minimizing tissue damage, and promoting quicker recovery with less scarring. According to the American Society of Plastic Surgeons in June 2024, minimally invasive procedures saw a 7% increase in 2023, outpacing the growth of traditional surgeries by 2%. This surge in demand is a key factor driving the expansion of the vascular lesion treatment laser market.
Companies in the vascular lesion treatment laser market are increasingly focusing on developing advanced solutions, such as dual-wavelength laser platforms, to improve treatment precision and patient comfort. These platforms combine two laser wavelengths in one system, allowing for more effective targeting of various vascular lesions while minimizing damage to surrounding tissue. For example, in April 2025, Candela Medical Inc., a US-based medical device company, introduced the Vbeam Pro laser platform, which integrates a 595 nm pulsed dye laser and a 1064 nm Nd:YAG wavelength. This dual-wavelength system is FDA-cleared for use in pediatric patients and offers greater precision and versatility for treating a range of vascular and dermatologic conditions, such as rosacea, port-wine stains, acne, and spider veins. The system also improves lesion clearance by 20%, reduces treatment times by 50%, and cuts patient discomfort by 20%, marking a significant advancement in pulsed dye laser technology.
In June 2023, Hahn and Company, a private equity firm based in South Korea, acquired Lutronic, a company specializing in advanced laser systems for treating vascular lesions. This acquisition strengthens Hahn and Company’s presence in the medical aesthetics market, leveraging Lutronic's innovative technologies and global reach to expand their offerings in this field.
Major companies operating in the vascular lesion treatment laser market are Lumenis Ltd., Candela Corporation, DEKA M.E.L.A. S.r.l., Alma Lasers Ltd., Quanta System S.p.A., Fotona d.o.o., Asclepion Laser Technologies GmbH, Aerolase Inc., Lynton Lasers Ltd., Sciton Inc., Cynosure Inc., Cutera Inc., Venus Concept Inc., Biolitec AG, El.En. S.p.A., SharpLight Technologies Ltd., Beijing Nubway S And T Co. Ltd., Beijing Sincoheren S And T Development Co. Ltd., Wuhan Gigaa Optronics Technology Co. Ltd., Nanjing Bestview Laser Co. Ltd.
North America was the largest region in the vascular lesion treatment laser market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular lesion treatment laser market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular lesion treatment laser market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased the cost of imported laser components, optical systems, cooling units, and electronic controls used in vascular lesion treatment lasers, raising equipment prices across the market. These impacts are most pronounced in advanced laser technologies such as pulsed dye, Nd:YAG, and diode lasers, particularly in Asia-Pacific and Europe where many high precision components are sourced internationally. Higher device costs have affected purchasing decisions in hospitals and dermatology clinics. However, tariffs have also encouraged local manufacturing and assembly of laser systems, supporting regional supply chains and improving long term cost stability.
The vascular lesion treatment laser market research report is one of a series of new reports that provides vascular lesion treatment laser market statistics, including vascular lesion treatment laser industry global market size, regional shares, competitors with a vascular lesion treatment laser market share, detailed vascular lesion treatment laser market segments, market trends and opportunities, and any further data you may need to thrive in the vascular lesion treatment laser industry. This vascular lesion treatment laser market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A vascular lesion treatment laser is a specialized medical laser system designed to target and treat abnormal or visible blood vessels, such as spider veins, hemangiomas, or port-wine stains, by delivering focused light energy. The laser selectively heats and collapses the blood vessels without damaging surrounding skin, resulting in clearer and healthier looking tissue.
The primary types of vascular lesion treatment lasers include telangiectasia, hemangiomas, varicose veins, and port wine stains. Telangiectasia refers to small, widened blood vessels visible on the skin’s surface, which can be treated with lasers to reduce redness and visible veins. Treatment technologies include pulsed dye lasers, neodymium-doped yttrium aluminum garnet lasers, intense pulsed light, diode lasers, and erbium lasers. These lasers are applied in areas such as aesthetic procedures, medical treatments, cosmetic enhancements, skin resurfacing, and tattoo removal. End users include hospitals, dermatology clinics, cosmetic surgery centers, ambulatory surgical centers, and home care settings.
The vascular lesion treatment laser market consists of revenues earned by entities by providing services such as spider vein removal, port-wine stain treatment, hemangioma treatment, rosacea management, telangiectasia treatment, and leg vein therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The vascular lesion treatment laser market also includes sales of alexandrite lasers, krypton lasers, argon lasers, copper vapor lasers, and ruby lasers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Vascular Lesion Treatment Laser Market Characteristics
3. Vascular Lesion Treatment Laser Market Supply Chain Analysis
4. Global Vascular Lesion Treatment Laser Market Trends and Strategies
5. Vascular Lesion Treatment Laser Market Analysis of End Use Industries
7. Global Vascular Lesion Treatment Laser Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Vascular Lesion Treatment Laser Total Addressable Market (TAM) Analysis for the Market
9. Vascular Lesion Treatment Laser Market Segmentation
10. Vascular Lesion Treatment Laser Market Regional and Country Analysis
11. Asia-Pacific Vascular Lesion Treatment Laser Market
12. China Vascular Lesion Treatment Laser Market
13. India Vascular Lesion Treatment Laser Market
14. Japan Vascular Lesion Treatment Laser Market
15. Australia Vascular Lesion Treatment Laser Market
16. Indonesia Vascular Lesion Treatment Laser Market
17. South Korea Vascular Lesion Treatment Laser Market
18. Taiwan Vascular Lesion Treatment Laser Market
19. South East Asia Vascular Lesion Treatment Laser Market
20. Western Europe Vascular Lesion Treatment Laser Market
21. UK Vascular Lesion Treatment Laser Market
22. Germany Vascular Lesion Treatment Laser Market
23. France Vascular Lesion Treatment Laser Market
24. Italy Vascular Lesion Treatment Laser Market
25. Spain Vascular Lesion Treatment Laser Market
26. Eastern Europe Vascular Lesion Treatment Laser Market
27. Russia Vascular Lesion Treatment Laser Market
28. North America Vascular Lesion Treatment Laser Market
29. USA Vascular Lesion Treatment Laser Market
30. Canada Vascular Lesion Treatment Laser Market
31. South America Vascular Lesion Treatment Laser Market
32. Brazil Vascular Lesion Treatment Laser Market
33. Middle East Vascular Lesion Treatment Laser Market
34. Africa Vascular Lesion Treatment Laser Market
36. Vascular Lesion Treatment Laser Market Competitive Landscape and Company Profiles
37. Vascular Lesion Treatment Laser Market Other Major and Innovative Companies
40. Vascular Lesion Treatment Laser Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Vascular Lesion Treatment Laser Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses vascular lesion treatment laser market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for vascular lesion treatment laser? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vascular lesion treatment laser market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Telangiectasia; Hemangiomas; Port Wine Stains2) By Technology: Pulsed Dye Laser; Neodymium-doped Yttrium Aluminum Garnet laser
3) By Application: Aesthetic Procedures; Medical Treatments; Cosmetic Enhancements
4) By End User: Hospitals; Dermatology Clinics; Cosmetic Surgery Centers
Subsegments:
1) By Telangiectasia: Facial Spider Veins; Leg Spider Veins; Truncal Spider Veins2) By Hemangiomas: Infantile Hemangiomas; Congenital Hemangiomas; Capillary Hemangiomas
3) By Port Wine Stains: Facial Port Wine Stains; Limb Port Wine Stains; Truncal Port Wine Stains
Companies Mentioned: Lumenis Ltd.; Candela Corporation; DEKA M.E.L.A. S.r.l.; Alma Lasers Ltd.; Quanta System S.p.A.; Fotona d.o.o.; Asclepion Laser Technologies GmbH; Aerolase Inc.; Lynton Lasers Ltd.; Sciton Inc.; Cynosure Inc.; Cutera Inc.; Venus Concept Inc.; Biolitec AG; El.En. S.p.A.; SharpLight Technologies Ltd.; Beijing Nubway S And T Co. Ltd.; Beijing Sincoheren S And T Development Co. Ltd.; Wuhan Gigaa Optronics Technology Co. Ltd.; Nanjing Bestview Laser Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Vascular Lesion Treatment Laser market report include:- Lumenis Ltd.
- Candela Corporation
- DEKA M.E.L.A. S.r.l.
- Alma Lasers Ltd.
- Quanta System S.p.A.
- Fotona d.o.o.
- Asclepion Laser Technologies GmbH
- Aerolase Inc.
- Lynton Lasers Ltd.
- Sciton Inc.
- Cynosure Inc.
- Cutera Inc.
- Venus Concept Inc.
- Biolitec AG
- El.En. S.p.A.
- SharpLight Technologies Ltd.
- Beijing Nubway S And T Co. Ltd.
- Beijing Sincoheren S And T Development Co. Ltd.
- Wuhan Gigaa Optronics Technology Co. Ltd.
- Nanjing Bestview Laser Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.03 Billion |
| Forecasted Market Value ( USD | $ 3.04 Billion |
| Compound Annual Growth Rate | 10.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
